One of the largest liquid choline plants in the world, the St. Gabriel location is undergoing an expansion due to the growing demand for choline products. Construction plans began earlier this year and commissioning is expected to be completed by the 2nd quarter of 2011.
The expansion is designed to ensure that production capabilities meet increasing customer demands.
The Verona plant expansion, scheduled to be completed in the first quarter 2011, is the result of on-going process and technology developments to meet the growing demand for Balchem’s AminoShure-L (Lysine) and ReaShure (Choline) products.
It incorporates internally developed novel technology that will streamline the current manufacturing process and expand the type of ingredients that can be encapsulated in support of strategic initiatives.
“With the expansion of the St. Gabriel plant, we continue to demonstrate our commitment to being the world leader in choline manufacturing,” said Dana Putnam, Vice President & General Manager of Balchem Animal Nutrition & Health.
“We believe both expansions will allow us to provide the best service and technology to our customers, while meeting the growing demand for high quality products.”
Balchem Corporation consists of three business segments:
- ARC Specialty Products, providing specialty-packaged chemicals for use in healthcare and other industries;
- Food, Pharma and Nutrition providing human grade choline as well as providing proprietary microencapsulation for a variety of applications in the human food, pharmaceutical and nutrition marketplaces, and
- Animal Nutrition and Health providing choline, microencapsulation and chelated mineral technology.